Abstract:Introduction: Congenital glucose–galactose malabsorption (CGGM) is a rare autosomal recessive disorder that primarily causes chronic intractable diarrhea. This study aims to describe the clinical history, laboratory profile, diagnostic workflow, and management of the first patient reported with CGGM in Mexico. Methods: The case involves a Mexican female infant with recurrent admissions to the emergency room since birth due to chronic diarrhea. Results: The infant was born at term by C-section with a birth weight of 3.120 kg and height of 48 cm for consanguineous parents. She had been breastfed until day 5 of her life when she presented lethargy, diarrhea, abdominal discomfort, and jaundice. During the first evaluation at the emergency room, the significant laboratory finding was blood tyrosine elevation; afterward, amino acid and succinylacetone determinations were obtained, discarding tyrosinemia. When admitted to the hospital, an abdominal ultrasound detected a duplex collecting system. At this time, rice formula was introduced to the patient. She was discharged with jaundice improvement, but diarrhea persisted. Several formula changes had been made from rice to extensively hydrolyzed casein protein to whey-based, with no clinical improvement; the patient still had 10–12 excretions daily. In the second hospitalization, the patient presented anemia, severe dehydration, hyperammonemia, and renal tubular acidosis. A next-generation sequencing panel for inborn errors of metabolism and congenital diarrhea was performed, identifying a homozygous variant in SLC5A1 (c.1667T > C). The diagnosis of CGGM was made at 3 months of age. The infant was initially treated with a modular galactose–glucose-free formula with oil, fructose, casein, minerals, and vitamins until a commercial fructose-based formula was introduced. This led to a complete resolution of diarrhea and improved nutritional status. Discussion: Diagnosing CGGM is challenging for clinicians, and next-generation sequencing is a valuable tool for providing appropriate treatment. More detailed information on patients with this condition might lead to possible phenotype–genotype correlations. This case's primary clinical and biochemical findings were chronic diarrhea, anemia, jaundice, renal tubular acidosis, hyperammonemia, and initial hypertyrosinemia. Symptoms were resolved entirely with the fructose-based formula.

The Adult Galactosemic Phenotype.

Health and well-being of maturing adults with classic galactosemia

N- and O-linked Glycosylation of Total Plasma Glycoproteins in Galactosemia.

Brain function in classic galactosemia, a galactosemia network (GalNet) members review

The natural history of classic galactosemia: lessons from the GalNet registry

Diagnosis of Inherited Disorders of Galactose Metabolism

Classic Galactosemia: Study on the Late Prenatal Development of GALT Specific Activity in a Sheep Model

Natural history of three late-diagnosed classic Galactosemia patients

A case report of classic galactosemia with a GALT gene variant and a literature review

Clinical and biochemical evolution after partial dietary liberalization of two cases of galactosemia due to galactose mutarotase deficiency

Social cognition, psychosocial development and well-being in galactosemia

Galactose-1-phosphate inhibits cytochrome c oxidase and causes mitochondrial dysfunction in classic galactosemia

A galactose‐1‐phosphate uridylyltransferase‐null rat model of classic galactosemia mimics relevant patient outcomes and reveals tissue‐specific and longitudinal differences in galactose metabolism

International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up

Social cognition, emotion-regulation and social competence in classical galactosemia patients without intellectual disability

Determination of the lactose and galactose content of common foods: Relevance to galactosemia

Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation

[Clinical characteristics and genetic analysis of a child with Galactosemia due to compound heterozygous variants of GALT gene]

ALG9-CDG: New Clinical Case and Review of the Literature

Importance of genetic sequencing studies in managing chronic neonatal diarrhea: a case report of a novel variant in the glucose–galactose transporter SLC5A1

Neuronal loss of Impairs O-glycosylation and Leads to Neurobehavioral Deficits Mimicking GALNT2-CDG